Intermountain Healthcare Names Chief Patient Safety and Experience Officer

SALT LAKE CITY, UTAH, USA, March 1, 2017 /EINPresswire.com/ — Shannon Connor Phillips, MD, MPH, has been named as Intermountain Healthcare’s Chief Patient Safety and Experience Officer. In this role, Dr. Phillips will work collaboratively with other Intermountain leaders to continually improve outcomes, safety, and the patient experience.

Dr. Phillips comes to Intermountain from Cleveland Clinic, where she is a physician lead in the Office of Clinical Transformation. She also served as Associate Chief Quality Officer and previously as the organization’s first Patient Safety Officer. In addition, she is on the National Quality Forum Expert Panel on Common Formats, a group focused on development of a national standard and repository for patient safety events. Dr. Phillips is recognized nationally and internationally for her expertise and leadership in safety, quality improvement, and culture in healthcare.

Dr. Phillips is a pediatrician and pediatric hospitalist with an interest in children with special healthcare needs. She joined Cleveland Clinic in 2004 to develop and lead a pediatric hospitalist medicine program and served as the first Cleveland Clinic Director of Pediatric Hospital Medicine. Previously, Dr. Phillips served at Riley Children’s Hospital in Indiana and Children’s Hospital of Philadelphia.

Dr. Phillips earned her medical degree from Columbia University College of Physicians & Surgeons in New York and her undergraduate degree from Emory College in Atlanta. She completed a pediatric internship and residency at George Washington University Children’s National Medical Center, in Washington, D.C. In addition, she earned a Master of Public Health degree at the Bloomberg School of Public Health, Johns Hopkins University.

Intermountain Healthcare is a Utah-based not-for-profit system of 22 hospitals, 185 clinics, a Medical Group with about 1,500 employed physicians and advanced practitioners, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Dental CAM Milling Machines Industry Global Supply & Consumption Analysis Market Report 2017

WiseGuyReports.Com Publish a New Market Research Report On – “Dental CAM Milling Machines Industry Global Supply & Consumption Analysis Market Report 2017”.

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ —

This report studies Dental CAD/CAM Milling Machines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
imes-icore
B&D Dental Technologies
Schutz Dental
Willemin-Macodel
Yenadent
DATRON
CadBlu Dental
Amann Girrbach
Wieland Dental + Technik
ROLAND DG
INTERDENT d.o.o.
vhf camfacture
Sirona Dental Systems
CHARLYROBOT
Bien-Air Dental
REITEL Feinwerktechnik
DENTAS
TDS Biotechnology
Zirkonzahn
Kavo
Diasu

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/934552-global-dental-cad-cam-milling-machines-market-research-report-2017

For more information or any query mail at sales@wiseguyreports.com

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Dental CAD/CAM Milling Machines in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II

Split by application, this report focuses on consumption, market share and growth rate of Dental CAD/CAM Milling Machines in each application, can be divided into
Application 1
Application 2

Complete Report Details @ https://www.wiseguyreports.com/reports/934552-global-dental-cad-cam-milling-machines-market-research-report-2017

Table Of Contents – Major Key Points

Global Dental CAD/CAM Milling Machines Market Research Report 2017
1 Dental CAD/CAM Milling Machines Market Overview
1.1 Product Overview and Scope of Dental CAD/CAM Milling Machines
1.2 Dental CAD/CAM Milling Machines Segment by Type
1.2.1 Global Production Market Share of Dental CAD/CAM Milling Machines by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Dental CAD/CAM Milling Machines Segment by Application
1.3.1 Dental CAD/CAM Milling Machines Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Dental CAD/CAM Milling Machines Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Dental CAD/CAM Milling Machines (2012-2022)

2 Global Dental CAD/CAM Milling Machines Market Competition by Manufacturers
2.1 Global Dental CAD/CAM Milling Machines Production and Share by Manufacturers (2015 and 2016)
2.2 Global Dental CAD/CAM Milling Machines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Dental CAD/CAM Milling Machines Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Dental CAD/CAM Milling Machines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Dental CAD/CAM Milling Machines Market Competitive Situation and Trends
2.5.1 Dental CAD/CAM Milling Machines Market Concentration Rate
2.5.2 Dental CAD/CAM Milling Machines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

…………

7 Global Dental CAD/CAM Milling Machines Manufacturers Profiles/Analysis
7.1 imes-icore
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 imes-icore Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 B&D Dental Technologies
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 B&D Dental Technologies Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Schutz Dental
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Schutz Dental Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Willemin-Macodel
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Willemin-Macodel Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Yenadent
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Yenadent Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 DATRON
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 DATRON Dental CAD/CAM Milling Machines Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 CadBlu Dental
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Dental CAD/CAM Milling Machines Product Type, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B

………..CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Buy This Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=934552

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Diabetic Peripheral Neuropathy Drugs and Companies Pipeline Review H2


Wise.Guy12

Wise.Guy.

Diabetic Peripheral Neuropathy Treatment Pipeline Review H2

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/619250-diabetic-peripheral-neuropathy-pipeline-review-h2-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global therapeutic landscape of Diabetic Peripheral Neuropathy
– The report reviews pipeline therapeutics for Diabetic Peripheral Neuropathy by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Diabetic Peripheral Neuropathy therapeutics and enlists all their major and minor projects
– The report assesses Diabetic Peripheral Neuropathy therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Diabetic Peripheral Neuropathy

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Diabetic Peripheral Neuropathy
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Diabetic Peripheral Neuropathy pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Content: Key Points
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Diabetic Peripheral Neuropathy Overview 7
Therapeutics Development 8
Pipeline Products for Diabetic Peripheral Neuropathy – Overview 8
Pipeline Products for Diabetic Peripheral Neuropathy – Comparative Analysis 9
Diabetic Peripheral Neuropathy – Therapeutics under Development by Companies 10
Diabetic Peripheral Neuropathy – Therapeutics under Investigation by Universities/Institutes 11
Diabetic Peripheral Neuropathy – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Diabetic Peripheral Neuropathy – Products under Development by Companies 15
Diabetic Peripheral Neuropathy – Products under Investigation by Universities/Institutes 16
Diabetic Peripheral Neuropathy – Companies Involved in Therapeutics Development 17
Achelios Therapeutics, Inc. 17
Celgene Corporation 18
Commence Bio, Inc. 19
Crescita Therapeutics Inc. 20
Glenmark Pharmaceuticals Ltd. 21

Access Report @ https://www.wiseguyreports.com/reports/619250-diabetic-peripheral-neuropathy-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Providence Health & Services Market 2017 Share, Trend, Segmentation and Forecast to 2020


Wise.Guy12

Wise.Guy.

Providence Health & Services Global Market Share, Opportunities, Research and Forecast to 2022

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — Providence Health & Services – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/504416-providence-health-services-strategic-swot-analysis-review

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy –Summarization of the company’s business strategy.
– SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights
Providence Health & Services (Providence) is a not for profit organization which offers health care services to its communities in Alaska, Washington, Montana, Oregon and California. The organization operates hospitals and physician clinics, and, provides senior services, supportive housing and educational services. The organization offers health care services through its physician clinics and family medicine centers, hospitals and medical centers, hospice and home health care, nursing homes and transitional care, PACE (Program of All-Inclusive Care for the Elderly) and adult day program, assisted and independent living and supportive housing. It offers health services in various therapeutic areas, such as, cardiology, orthopedics, cancer, neuroscience, woman’s health and other specialties. Providence is headquartered in Renton, Washington, the US.

Providence Health & Services Key Recent Developments
Aug 20, 2015: Walgreens and Providence Health & Services form strategic clinical collaboration to improve and coordinate patient care

Reasons to Buy
– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Access Report @ https://www.wiseguyreports.com/reports/504416-providence-health-services-strategic-swot-analysis-review

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 5
Providence Health & Services – Key Facts 6
Providence Health & Services – Key Employees 7
Providence Health & Services – Key Employee Biographies 9
Providence Health & Services – Major Products and Services 10
Providence Health & Services – History 11
Providence Health & Services – Company Statement 14
Providence Health & Services – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 18
Section 2 – Company Analysis 19
Providence Health & Services – Business Description 19
Providence Health & Services – Corporate Strategy 20
Providence Health & Services – SWOT Analysis 21
SWOT Analysis – Overview 21
Providence Health & Services – Strengths 21
Strength – Operational Network 21
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Lupin Ltd. Therapeutic and Drug Pipeline Review


Wise.Guy12

Wise.Guy.

Global Lupin Ltd. Drugs and Companies Pipeline Review 2017

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Lupin Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/619241-lupin-limited-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Lupin Limited
– The report provides overview of Lupin Limited including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Lupin Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Lupin Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Lupin Limited’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Lupin Limited
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Lupin Limited’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 5
Lupin Limited Snapshot 6
Lupin Limited Overview 6
Key Information 6
Key Facts 6
Lupin Limited – Research and Development Overview 7
Key Therapeutic Areas 7
Lupin Limited – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Lupin Limited – Pipeline Products Glance 12
Lupin Limited – Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Lupin Limited – Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Lupin Limited – Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Lupin Limited – Unknown Stage Pipeline Products 17
Unknown Products/Combination Treatment Modalities 17
Lupin Limited – Drug Profiles 18
Biosimilar for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
etanercept biosimilar 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
LND-101001 20
Product Description 20

Access Report @ https://www.wiseguyreports.com/reports/619241-lupin-limited-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Organic Personal Care Products Market 2017 Share, Trend, Segmentation and Forecast to 2022

focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — Organic Personal Care Products

Summary

This report studies Organic Personal Care Products in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Aveda
Bare Escentuals
Burt's Bee
Estee Lauder
Kiehl's
The Body Shop
Arbonne
Aubrey Organics
Clorox
Colgate-Palmolive
Colomer
Gabriel Cosmetics
Giovanni Cosmetics
Iredale Mineral Cosmetics

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/980031-global-organic-personal-care-products-market-research-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Organic Personal Care Products in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Skin Care
Hair Care
Oral Care
Others

Split by application, this report focuses on consumption, market share and growth rate of Organic Personal Care Products in each application, can be divided into
Men
Women

……

At any Query @ https://www.wiseguyreports.com/enquiry/980031-global-organic-personal-care-products-market-research-report-2017

Table of Contents

Global Organic Personal Care Products Market Research Report 2017
1 Organic Personal Care Products Market Overview
1.1 Product Overview and Scope of Organic Personal Care Products
1.2 Organic Personal Care Products Segment by Type
1.2.1 Global Production Market Share of Organic Personal Care Products by Type in 2015
1.2.2 Skin Care
1.2.3 Hair Care
1.2.4 Oral Care
1.2.5 Others
1.3 Organic Personal Care Products Segment by Application
1.3.1 Organic Personal Care Products Consumption Market Share by Application in 2015
1.3.2 Men
1.3.3 Women
1.4 Organic Personal Care Products Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Organic Personal Care Products (2012-2022)

…..

7 Global Organic Personal Care Products Manufacturers Profiles/Analysis
7.1 Aveda
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Organic Personal Care Products Product Type, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Aveda Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Bare Escentuals
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Organic Personal Care Products Product Type, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bare Escentuals Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Burt's Bee
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Organic Personal Care Products Product Type, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Burt's Bee Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Estee Lauder
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Organic Personal Care Products Product Type, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Estee Lauder Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Kiehl's
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Organic Personal Care Products Product Type, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Kiehl's Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 The Body Shop
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Organic Personal Care Products Product Type, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 The Body Shop Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Arbonne
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Organic Personal Care Products Product Type, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Arbonne Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Aubrey Organics
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Organic Personal Care Products Product Type, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Aubrey Organics Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Clorox
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Organic Personal Care Products Product Type, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Clorox Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Colgate-Palmolive
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Organic Personal Care Products Product Type, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Colgate-Palmolive Organic Personal Care Products Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Colomer
7.12 Gabriel Cosmetics
7.13 Giovanni Cosmetics
7.14 Iredale Mineral Cosmetics

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=980031

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

IQ4I Research & Consultancy published a new report on “Aortic Aneurysm Repair Devices Global Market – Forecast To 2023”

This report Contains 132 market data tables and 58 figures spread through 341 pages and an exhaustive TOC.

Aortic Aneurysm Repair Devices Global Market estimated to be worth $3,448.2 million by 2023”

— IQ4I Analyst

BOSTON, MASSACHUSETTS, U.S., February 28, 2017 /EINPresswire.com/ — The aorta is the main artery in the body that carries oxygen-rich blood from the heart to other parts of the body. An aortic aneurysm refers to an enlargement (or dilation) of the aorta to greater than 1.5 times normal size. Aortic aneurysm symptoms often do not show up until an aneurysm becomes large or bursts and cause bleeding or even death. But as it grows, some signs including, chest or back pain, difficulty breathing or swallowing, shortness of breath, coughing, hoarseness can be noticed. Other causes for an aneurysm may include, high blood pressure, infection, plaque build-up in arteries (atherosclerosis), smoking, high cholesterol and sudden traumatic injury. Based on the location, an aortic aneurysm is classified into two type’s Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). According to IQ4I analysis, the Aortic Aneurysm repair devices global market is expected to grow at a mid single digit CAGR from 2016-2023.

Rising geriatric population, increasing the number of lifestyle diseases, growing acceptance for minimally invasive endovascular surgeries and technological advancements in EVAR are expected to propel the growth of Aortic Aneurysm Repair Devices global market. However, some issues like risks associated with endovascular procedures such as endoleaks, radiation exposure and high costs of endovascular aneurysm repair procedures may hinder the growth of Aortic Aneurysm repair devices market.

The Aortic Aneurysm Repair Devices global market by site is segmented into Abdominal Aortic Aneurysm (Infrarenal and Perarenal) and Thoracic Aortic Aneurysm (Ascending, Descending, Thoracoabdominal and Aortic Arch). The Abdominal Aortic Aneurysm contributed the largest revenue in 2016 as per estimates of IQ4I Research. Thoracic Aortic Aneurysm is expected to grow at the highest CAGR by 2023. The Aortic Aneurysm Repair Devices global market by products is segmented into Stent grafts, Catheters and Others. The stents grafts occupied highest market in 2016 of Aortic Aneurysm Repair Devices product market.

The Aortic Aneurysm Repair Devices global market by Repair Type is segmented into Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. Abdominal Aortic Aneurysm is segmented into Open surgery repair and Endovascular aortic repair (EVAR). The endovascular aneurysm repair occupied largest market share in Abdominal Aortic Aneurysm Repair Devices by repair type market and is expected to grow at a high CAGR. Thoracic Aortic Aneurysm by repair type is segmented into Open surgery and Thoracic endovascular aneurysm repair (TEVAR). The Thoracic endovascular aneurysm repair contributed the largest revenue and is expected to grow at a high CAGR as per estimates of IQ4I Research.

The Aortic Aneurysm Repair Devices global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue in 2016 due to advanced healthcare infrastructure, constant technological innovations, increase in lifestyle diseases and growing acceptance for minimally invasive endovascular surgeries. However, Asia-pacific region is expected to grow at the highest CAGR due to due to changing lifestyle, increasing healthcare expenditure and growing public awareness towards minimally invasive surgeries.

Some of the prominent players in aortic aneurysm repair devices market include Bolton Medical (U.S.), Cook Medical (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Medtronic plc (Ireland), MicroPort Scientific Corporation (China),Terumo Medical Corporation (Japan), W.L. Gore and Associates, Inc. (U.S). Some of the emerging players are JOTEC GmbH (Germany), LifeTech Scientific Inc. (China), Endospan (Israel), Nano Endoluminal S.A. (Brazil), Braile Biomedica (Brazil) etc.

Mr. Satish Biruddukota
IQ4I Research & Consultancy Pvt Ltd.,
+91-80-60500229
email us here


Source: EIN Presswire

Wockhardt Ltd. Pharmaceutical and Healthcare Pipeline Review H2


Wise.Guy12

Wise.Guy.

Wockhardt Ltd. Treatment Pipeline Review H2 2016

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — *Get Flat 15% discount*
Summary
This report provides comprehensive information on the current therapeutic developmental pipeline of Wockhardt Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/306790-wockhardt-limited-product-pipeline-review-2015

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope
– The report provides brief overview of Wockhardt Limited including business description, key information and facts, and its locations and subsidiaries
– The report reviews current pipeline of Wockhardt Limited’s human therapeutic division and enlists all their major and minor projects
– The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
– Special feature on out-licensed and partnered product portfolio
– The report summarizes all the dormant and discontinued pipeline projects
– Latest company statement
– Latest news and deals relating to the Wockhardt Limited’s pipeline products

Reasons to buy
– Evaluate Wockhardt Limited’s strategic position with total access to detailed information on its product pipeline
– Assess the growth potential of Wockhardt Limited in its therapy areas of focus
– Identify new drug targets and therapeutic classes in the Wockhardt Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
– Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
– Develop strategic initiatives by understanding the focus areas of Wockhardt Limited and exploit collaboration and partnership opportunities
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Plan mergers and acquisitions effectively by identifying the most promising pipeline of Wockhardt Limited
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Explore the dormant and discontinued projects of Wockhardt Limited and identify potential opportunities in those areas
– Avoid Intellectual Property Rights related issues
…Continued

Access Report @ https://www.wiseguyreports.com/reports/306790-wockhardt-limited-product-pipeline-review-2015

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

BPO Services Global Market Opportunity and Major Players Analysis 2022


Wise.Guy12

Wise.Guy.

BPO Services Global Market Share, Opportunities, Segmentation and Forecast to 2021

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — Summary
BPO Services Global Industry Almanac_2016 is a comprehensive study outlaying the current market scenario, future prospective and detailed industry insights of BPO Services market globally. The study pegs that the global BPO services market had total revenues of $138.6bn in 2015, representing a compound annual growth rate (CAGR) of 6.9% between 2011 and 2015.
As per the report, BPO services include the outsourcing of business-related processes to third-party organisations. The services include the outsourcing of functions such as customer relationship management, finance & accounting, human resources, procurement, and vertical-specific processes.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/605837-bpo-services-global-industry-almanac_2016

The CRM BPO segment contributed revenues of $37.5bn in 2015, equating to 27.1% of the market's aggregate value. Further it provides, detailed industry analysis with help of Five Force Model at overall regional level and for 25 countries globally, analyzed within this report.
In order to have industry accepted standard comparative scenario – in this report,

Key Findings
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global bpo services market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global bpo services market
Leading company profiles reveal details of key bpo services market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the global bpo services market with five year forecasts
Compares data from 25 countries globally, alongside individual chapters on each country.

Synopsis
Global BPO Services industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-2015, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Reasons to Buy
What was the size of the global bpo services market by value in 2015?
What will be the size of the global bpo services market in 2020?
What factors are affecting the strength of competition in the global bpo services market?
How has the market performed over the last five years?
What are the main segments that make up the global bpo services market?

Key Highlights
The global BPO services market had total revenues of $138.6bn in 2015, representing a compound annual growth rate (CAGR) of 6.9% between 2011 and 2015.
BPO services include the outsourcing of business-related processes to third-party organisations. The services include the outsourcing of functions such as customer relationship management, finance & accounting, human resources, procurement, and vertical-specific processes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
The vertical-specific BPO segment was the market's most lucrative in 2015, with total revenues of $38.9bn, equivalent to 28.1% of the market's overall value.
The biggest reason behind using the BPO services by companies around the word is to rationalise costs, improve performance and increase consumer satisfaction. The main drivers for the BPO market growth are technology infusion, scalability, quality, best-of-breed process and improved service levels.

Table of Contents
EXECUTIVE SUMMARY
Market value
Market value forecast
Category segmentation
Geography segmentation
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global BPO Services
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
BPO Services in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
…Continued

Access Report @ https://www.wiseguyreports.com/reports/605837-bpo-services-global-industry-almanac_2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=t

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

2017-2021 UK Proton Therapy Market Size, Share, Trends, Opportunities & Forecast

UK Proton Therapy Market is expected to grow with a CAGR of 82% in future

PUNE, INDIA, February 28, 2017 /EINPresswire.com/ — United Kingdom Proton Therapy Industry

Key Companies Covered
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)

United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast is a research study published Renub Research. UK Proton Therapy Market is expected to grow with a CAGR of 82% in future. United Kingdom Proton Therapy Market is expected to grow 10 times from its current market in 2016. Currently UK has only one Proton Therapy facility, at Clatterbridge cancer center and it’s a ‘low-energy’ machine, only suitable for treating people with rare eye cancers. Treating more complex cancers requires a ‘high-energy’ beam, so the NHS covers the cost of sending patients for treatment overseas (in the US or Switzerland) when there’s clear evidence that proton beam therapy is the best option. However this scenario is expected to make a drastic change in the next few years as United Kingdom will have at least 6 Proton Therapy Centers.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/1000725-united-kingdom-uk-proton-therapy-market-reimbursement-policy-patients-treated-at

The report provides a comprehensive assessment of the fast-evolving, high-growth of Proton Therapy Market. In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report also talks about list of all Operational and about to be opened Proton Therapy Facility; Proton Therapy Reimbursement Policies in United Kingdom. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

a) Actual Market is the current market which is already present

b) Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/1000725-united-kingdom-uk-proton-therapy-market-reimbursement-policy-patients-treated-at

United Kingdom Proton Therapy Market has been analyzed from four view points

• UK Proton Therapy Actual Market & Forecast (2009 – 2021)
• UK Proton Therapy Untapped Market & Forecast (2009 – 2021)
• UK Proton Therapy Treated Patient Numbers & Forecast (2009 – 2021)
• UK Proton Therapy Untapped Patient Numbers & Forecast (2009 – 2021)

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/1000725-united-kingdom-uk-proton-therapy-market-reimbursement-policy-patients-treated-at

Key Questions Answered in the Report?
• What is the Proton Therapy Market in United Kingdom & its growth potential in Future?
• What is the untapped market in United Kingdom Proton Therapy and its Future?
• How many Proton Therapy Facilities are operating in United Kingdom?
• How many Proton Therapy Facilities are going to open in near Future?
• What is the number of people being treated in these Proton Therapy Centers yearly?
• Is Proton Therapy Treatment being covered in the Reimbursement policy of United Kingdom?
• What are the sales of Proton Therapy Companies Globally (IBA, Varian, Elekta)?

Some Major Points from Table of content:

Executive Summary

2. United Kingdom Proton Therapy Market – Actual & Untapped Market
2.1 United Kingdom – Proton Therapy Market
2.2 United Kingdom – Untapped Proton Therapy Market

3. United Kingdom Proton Therapy Patient Number – Actual and Untapped
3.1 United Kingdom – Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United Kingdom – Patients with Proton Therapy Untapped Numbers & Forecast

4. United Kingdom – List of Proton Therapy Centers

5. United Kingdom – Proton Therapy Treated Patients by Centers
5.1 Clatterbridge Proton Therapy Center

Continued…..

For more information or any query mail at sales@wiseguyreports.com

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire